Drug interactions in African herbal remedies (Q37901060)

25 August 2017

1 reference

title

Drug interactions in African herbal remedies (English)

1 reference

25 August 2017

Werner Cordier

1

1 reference

PubMed ID

21756221

25 August 2017

Vanessa Steenkamp

series ordinal

2

1 reference

25 August 2017

15 July 2011

1 reference

Drug Metabolism and Drug Interactions

25 August 2017

1 reference

25 August 2017

26

1 reference

25 August 2017

2

1 reference

25 August 2017

53-63

1 reference

The efficacy of herbal medicine--an overview

25 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

The effect of complimentary and alternative medicine products on laboratory testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Antimutagenic potential of the Thai herb, Mucuna collettii Lace

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Potential health risks of complementary alternative medicines in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Safety of herbal supplements: a guide for cardiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

In vitro inhibitory effect of West African medicinal and food plants on human cytochrome P450 3A subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Impact of African herbal medicines on antiretroviral metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Evaluation of cytotoxic, genotoxic and CYP450 enzymatic competition effects of Tanzanian plant extracts traditionally used for treatment of fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Grapefruit-drug interactions: can interactions with drugs be avoided?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Drug interactions between antiretroviral drugs and comedicated agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Screening of Tanzanian plant extracts for their potential inhibitory effect on P-glycoprotein mediated efflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Impact of traditional medicinal plant extracts on antiretroviral drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Cytochrome P450s and other enzymes in drug metabolism and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Expression of cytochrome P450 3A in amphibian, rat, and human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Selective expression of CYP3A5 and not CYP3A4 in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Cytochromes P450 and metabolism of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Role of evolutionary history on haplotype block structure in the human genome: implications for disease mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Characterization of the genetic profile of CYP2C19 in two South African populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

The effect of Sutherlandia frutescens on steroidogenesis: confirming indigenous wisdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Cytochrome P450 17alpha hydroxylase/17,20 lyase (CYP17) function in cholesterol biosynthesis: identification of squalene monooxygenase (epoxidase) activity associated with CYP17 in Leydig cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

The influence of Sutherlandia frutescens on adrenal steroidogenic cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

CYP21 pseudogene transcripts are much less abundant than those from the active gene in normal human adrenocortical cells under various conditions in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Interaction of CYP11B1 (cytochrome P-45011 beta) with CYP11A1 (cytochrome P-450scc) in COS-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Effects of herbal medicinal products and food supplements on induction of CYP1A2, CYP3A4 and MDR1 in the human colon carcinoma cell line LS180.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

beta-Sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: implications for their use as an immunomodulatory vitamin combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Anti-HIV activities of organic and aqueous extracts of Sutherlandia frutescens and Lobostemon trigonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

A review of the biological and potential therapeutic actions of Harpagophytum procumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Biological and pharmacological activities of iridoids: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Traditional remedies and food supplements. A 5-year toxicological study (1991-1995).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

A review of the bioactivity of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

South African herbal teas: Aspalathus linearis, Cyclopia spp. and Athrixia phylicoides--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Modulation of hepatic drug metabolizing enzymes and oxidative status by rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia), green and black (Camellia sinensis) teas in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Effects of continuous ingestion of herbal teas on intestinal CYP3A in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Effects of dietary supplements on induction and inhibition of cytochrome P450s protein expression in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Effect of Aloe vera preparations on the human bioavailability of vitamins C and E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Caco-2 cell methodology and inhibition of the P-glycoprotein transport of digoxin by Aloe vera juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Tailoring the network properties of Ca2+ crosslinked Aloe vera polysaccharide hydrogels for in situ release of therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Possible interaction between sevoflurane and Aloe vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Variability of CYP3A7 expression in human fetal liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

(-)-Roemerine, an aporphine alkaloid from Annona senegalensis that reverses the multidrug-resistance phenotype with cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Effect of gum arabic on the absorption of a single oral dose of amoxicillin in healthy Sudanese volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Cytochrome P450 2D6 (CYP2D6) inhibitory constituents of Catharanthus roseus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Effect of Khat chewing on the bioavailability of ampicillin and amoxycillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

Medical provision in Africa - Past and present

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2011.011

21 January 2018

Identifiers

DOI

10.1515/DMDI.2011.011

1 reference

25 August 2017

1 reference

PubMed ID

21756221